Phase 1/2a study of navitoclax (abt-263) in relapsed or refractory lymphoid malignancies Meeting Abstract


Authors: Wilson, H.; O'Connor, A.; Czuczman, S.; LaCasce, S.; Gerecitano, F.; Leonard, P.; Tulpule, A.; Xiong, H.; Chiu, Y. L.; Busman, T.; Enschede, H.; Krivoshik, P.; Humerickhouse, H.
Abstract Title: Phase 1/2a study of navitoclax (abt-263) in relapsed or refractory lymphoid malignancies
Meeting Title: 15th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 95
Issue: Suppl. 2
Meeting Dates: 2010 Jun 10-13
Meeting Location: Barcelona, Spain
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2010-06-01
Start Page: 116
End Page: 117
Language: English
ACCESSION: ISI:000279051300292
PROVIDER: wos
PMCID: PMC2888565
Notes: --- - Meeting Abstract: 0292 - "Source: Wos"
MSK Authors